Clinical Trial Update: A Prospective Clinical Trial Evaluating PROSTest, a Blood-Based Molecular Assay, for Risk Stratification and Biopsy Decision Support in Men With Suspected Prostate Cancer

View source ↗

Summary

A prospective clinical trial is evaluating PROSTest, a blood-based molecular assay, to risk-stratify men with suspected prostate cancer and aid biopsy decisions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Wren Laboratories LLC | Conditions: Prostate Cancer, Urology | Status: NOT_YET_RECRUITING